Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Annals of Clinical Biochemistry
|
June 22, 1999
Is the Bayer DCA 2000 acceptable as a screening instrument for the early detection of renal disease?
M D Shephard, L J Barratt, W Simpson-Lyttle
The Medical Journal of Australia
|
April 3, 1982
Urinalysis in an Australian teaching hospital
M D Shephard, L A Penberthy, C G Fraser
Clinical Chemistry
|
April 1, 1981
Short- and long-term biological variation in analytes in urine of apparently healthy individuals
M D Shephard, L A Penberthy, C G Fraser
Journal of Clinical Pathology
|
September 1, 1986
Quantitative method for determining serum alkaline phosphatase isoenzyme activity II. Development and clinical application of method for measuring four serum alkaline phosphatase isoenzymes
M D Shephard, M J Peake, R N Walmsley
Journal of Clinical Pathology
|
October 1, 1987
Adaptation of methods for glutamate dehydrogenase and alcohol dehydrogenase activities to a centrifugal analyser: assessment of their clinical use in anoxic states of the liver
M D Shephard, L A Penberthy, M N Berry
Pathology
|
July 1, 1982
A quality assurance programme for quantitative urine analyses
M D Shephard, L A Penberthy, C G Fraser
Diabetes Care
|
January 1, 1997
Measurement of plasma LDL cholesterol in patients with diabetes
M J Whiting, M D Shephard, G A Tallis
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 31, 1995
The total apolipoprotein B/LDL-cholesterol ratio dose not predict LDL particle size
G A Tallis, M D Shephard, S Sobecki, et al.
Annals of Clinical Biochemistry
|
July 1, 1989
Fasting specimens not required for routine measurement of plasma apolipoproteins A-I and B
J Hester, M D Shephard, R N Walmsley, et al.
Annals of Clinical Biochemistry
|
January 1, 1990
Variation in plasma apolipoprotein A-1 and B concentrations following myocardial infarction
M D Shephard, J Hester, R N Walmsley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Annals of Clinical Biochemistry
|
June 22, 1999
Is the Bayer DCA 2000 acceptable as a screening instrument for the early detection of renal disease?
M D Shephard, L J Barratt, W Simpson-Lyttle
The Medical Journal of Australia
|
April 3, 1982
Urinalysis in an Australian teaching hospital
M D Shephard, L A Penberthy, C G Fraser
Clinical Chemistry
|
April 1, 1981
Short- and long-term biological variation in analytes in urine of apparently healthy individuals
M D Shephard, L A Penberthy, C G Fraser
Journal of Clinical Pathology
|
September 1, 1986
Quantitative method for determining serum alkaline phosphatase isoenzyme activity II. Development and clinical application of method for measuring four serum alkaline phosphatase isoenzymes
M D Shephard, M J Peake, R N Walmsley
Journal of Clinical Pathology
|
October 1, 1987
Adaptation of methods for glutamate dehydrogenase and alcohol dehydrogenase activities to a centrifugal analyser: assessment of their clinical use in anoxic states of the liver
M D Shephard, L A Penberthy, M N Berry
Pathology
|
July 1, 1982
A quality assurance programme for quantitative urine analyses
M D Shephard, L A Penberthy, C G Fraser
Diabetes Care
|
January 1, 1997
Measurement of plasma LDL cholesterol in patients with diabetes
M J Whiting, M D Shephard, G A Tallis
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 31, 1995
The total apolipoprotein B/LDL-cholesterol ratio dose not predict LDL particle size
G A Tallis, M D Shephard, S Sobecki, et al.
Annals of Clinical Biochemistry
|
July 1, 1989
Fasting specimens not required for routine measurement of plasma apolipoproteins A-I and B
J Hester, M D Shephard, R N Walmsley, et al.
Annals of Clinical Biochemistry
|
January 1, 1990
Variation in plasma apolipoprotein A-1 and B concentrations following myocardial infarction
M D Shephard, J Hester, R N Walmsley, et al.
Page
of 3